Insider filing · GH
Helmy Eltoukhy
Co-Chief Executive Officer
profile →
Guardant Health, Inc.
GH · Healthcare · 58 filings in 24 months
ticker →
Helmy Eltoukhy sold $12.5M of Guardant Health (GH)
Executed Jun 5, disclosed Jun 8, 3 days later.
Value, as filed
$12.5M
99,346 sh across 5 lots
Executed
Jun 5
the trade date, as filed
Disclosed
Jun 8
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HEHelmy Eltoukhy (Co-Chief Executive Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Guardant Health, Inc. (GH). The largest single filing was $12.5M of GH (99,346 sh across 5 lots, as filed), executed Jun 5.
The name
GHHealthcare · Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Helmy Eltoukhy in GH
GHSALE
Guardant Health, Inc.
$9.4M90,565 sh across 2 lots
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET GHSALE Guardant Health, Inc. $17.8M
300,000 sh across 2 lots
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET